Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Sep 2;17(1):433.
doi: 10.1186/s13063-016-1553-4.

Effect of physical exercise training in patients with Chagas heart disease: study protocol for a randomized controlled trial (PEACH study)

Fernanda de Souza Nogueira Sardinha Mendes  1 , Andréa Silvestre Sousa  2 , Fernando Cesar de Castro Cesar Souza  3 , Vivian Liane Mattos Pinto  2 , Paula Simplicio Silva  2 , Roberto Magalhães Saraiva  2 , Sergio Salles Xavier  2 , Henrique Horta Veloso  2 , Marcelo Teixeira Holanda  2 , Andréa Rodrigues Costa  2 , Fernanda Martins Carneiro  2 , Gilberto Marcelo Sperandio Silva  2 , Juliana Pereira Borges  3   4   5 , Eduardo Tibirica  3   5 , Roberta Olmo Pinheiro  5 , Flávio Alves Lara  5 , Alejandro Marcel Hasslocher-Moreno  2 , Pedro Emmanuel Alvarenga Americano Brasil  2 , Mauro Felippe Felix Mediano  2
Affiliations
Randomized Controlled Trial

Effect of physical exercise training in patients with Chagas heart disease: study protocol for a randomized controlled trial (PEACH study)

Fernanda de Souza Nogueira Sardinha Mendes et al. Trials. .

Abstract

Background: The effects of exercise training on Chagas heart disease are still unclear. This study aimed to evaluate the effect of exercise training over functional capacity, cardiac function, quality of life, and biomarkers in Chagas heart disease.

Methods: The PEACH study is a superiority randomized clinical trial which will include subjects who meet the following criteria: Chagas heart disease with a left ventricular ejection fraction below 45 % with or without heart failure symptoms; clinical stability in the last 3 months; adherence to clinical treatment; and age above 18 years. The exclusion criteria are: pregnancy; neuromuscular limitations; smoking; evidence of non-chagasic heart disease; systemic conditions that limit exercise practice or cardiopulmonary exercise test; unavailability to attend the center three times a week during the intervention period; and practitioners of regular exercise. The intervention group will perform an exercise training intervention three times per week during 6 months and will be compared to the control group without exercise. Both groups will undergo the same monthly pharmaceutical and nutritional counseling as well as standard medical treatment according to the Brazilian consensus on Chagas disease. The primary outcome is functional capacity based on peak exercise oxygen consumption during cardiopulmonary exercise testing. Secondary outcomes are: cardiac function; body composition; muscle respiratory strength; microvascular reactivity; cardiac rhythm abnormalities; autonomic function; biochemical; oxidative stress and inflammatory biomarkers; and quality of life. Subjects will be evaluated at baseline, and at 3 and 6 months after randomization. Thirty patients will be randomly assigned into exercise or control groups at a ratio of 1:1.

Discussion: Findings of the present study will be useful to determine if physical exercise programs should be included as an important additional therapy in the treatment of patients with Chagas heart disease.

Trial registration: ClinicalTrials.gov ID: NCT02517632 (registered on 6 August 2015).

Keywords: Cardiac rehabilitation; Cardiopulmonary exercise test; Chagas heart disease; Exercise training; Heart failure.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram of the PEACH study protocol
Fig. 2
Fig. 2
Medication packages
Fig. 3
Fig. 3
Schedule of enrollment, interventions, and assessments of the PEACH study
See this image and copyright information in PMC

References

    1. Bern C. Chagas’ disease. N Engl J Med. 2015;373(5):456–66. doi: 10.1056/NEJMra1410150. - DOI - PubMed
    1. Rassi A, Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388–402. doi: 10.1016/S0140-6736(10)60061-X. - DOI - PubMed
    1. Ministerio da Saude. Secretaria de Vigilancia em S. Brazilian consensus on Chagas disease. Rev Soc Bras Med Trop. 2005;38 Suppl 3:7–29. - PubMed
    1. Ribeiro AL, Nunes MP, Teixeira MM, Rocha MO. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol. 2012;9(10):576–89. doi: 10.1038/nrcardio.2012.109. - DOI - PubMed
    1. Brush JE, Jr, Handberg EM, Biga C, Birtcher KK, Bove AA, Casale PN, Clark MG, Garson A, Jr, Hines JL, Linderbaum JA, et al. 2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of Advanced Practice Providers. J Am Coll Cardiol. 2015;65(19):2118–36. doi: 10.1016/j.jacc.2015.03.550. - DOI - PubMed

Publication types

MeSH terms

Associated data